Senesco

Senesco Announces Reverse Stock Split
Yahoo/BusinessWire
Sat, 10/19/13 - 03:48 pm
Senesco
Senesco’s Lead Therapeutic Candidate, SNS01-T, Granted Orphan Drug Status from FDA for Treatment of Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
Yahoo
Mon, 07/30/12 - 11:06 am
Senesco
SNS01-T
orphan drugs
mantle cell lymphoma
diffuse large B-cell lymphoma